Pargluva Approval Status beta

  • FDA approved: No
  • Brand name: Pargluva
  • Generic name: muraglitazar
  • Company: Bristol-Myers Squibb and Merck & Co., Inc.
  • Treatment for: Diabetes, Type 2

FDA Approval Status for Pargluva

DateArticle
Oct 27, 2005Bristol-Myers Squibb Statement on Muraglitazar, an Investigational Oral Treatment For Type 2 Diabetes
Oct 18, 2005Bristol-Myers Squibb and Merck Joint Statement on Regulatory Status of Pargluva (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes
Sep  9, 2005Bristol-Myers Squibb and Merck Joint Statement on FDA Advisory Committee Vote on Pargluva (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes
Dec 23, 2004Bristol-Myers Squibb Provides Regulatory Update for Muraglitazar

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)